OMG and multiple sclerosis: Statistical analyses were conducted separately in each cohort.<h4>Results</h4>We detected lower plasma OMG in individuals with cortical amyloid deposition, compromised brain structure, dementia, and multiple sclerosis, as well as in individuals who developed dementia over 7- to 20-year follow-up periods.